The purpose of the Biostatistics and Data Management Core for this program project is to provide a? comprehensive, multi-disciplinary resource for design of clinical and basic science experiments,? development of appropriate and innovative statistical methodology, statistical analysis, and summarizing the? results. The Biostatistics and Data Management Core has the following overall goals: to provide statistical? consulting and collaboration on the design, conduct, analysis and interpretation of all program project? research studies and cores, and to provide, manage and maintain a high-quality research database that? supports the research projects and cores while preserving the confidentiality of all subject data. The specific? aims are: (1) Coordinate and manage statistical activities in the program project to ensure that investigators? have ready access to statistical consultation and support. (2) Provide statistical expertise in the design of? experiments and studies, including research proposal development, sample size determination,? randomization procedures, and plans for interim reviews and final analysis. (3) Assist with the writing of? statistical components of manuscripts. (4) Review, in conjunction with the Clinical Translational Review? Committee, the integrity and statistical soundness of all studies involving human subjects. (5) Provide? statistical analysis for all projects using appropriate statistical and computing methodologies, assist in the? interpretation and presentation of results. (6) Interact and collaborate with the Clinical Trials and? Translational Research Office in the development of protocols and the monitoring and reporting of clinical? data. (7) Maintain a computing facility with up-to-date software for statistical analysis to support program? project investigators. (8) Conduct biostatistical methodology research on practical problems arising in cancer? studies. (9) Provide computer-based tools that facilitate the storage and retrieval of the data generated in the? proposed research, thereby creating and maintaining a centralized relational database that provides access? to common resources and information. (10) Ensure the accuracy of the data maintained in the database by? software based data consistency and quality control systems. (11) Organize and maintain the database to? maximize accuracy and accessibility; while maintaining strict confidentiality. (12) Provide detailed? descriptions of the available populations and resources for current and future investigators. (13) Provide? high-quality data entry services.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA116676-03
Application #
7625950
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2008-06-01
Budget End
2009-05-31
Support Year
3
Fiscal Year
2008
Total Cost
$132,148
Indirect Cost
Name
Emory University
Department
Type
DUNS #
066469933
City
Atlanta
State
GA
Country
United States
Zip Code
30322
Liu, Fakeng; Liu, Yuan; Liu, Xiuju et al. (2018) Inhibition of IGF1R enhances 2-deoxyglucose in the treatment of non-small cell lung cancer. Lung Cancer 123:36-43
Li, Zenggang; Ivanov, Andrei A; Su, Rina et al. (2017) The OncoPPi network of cancer-focused protein-protein interactions to inform biological insights and therapeutic strategies. Nat Commun 8:14356
Zhang, Jun; Nannapaneni, Sreenivas; Wang, Dongsheng et al. (2017) Phenformin enhances the therapeutic effect of selumetinib in KRAS-mutant non-small cell lung cancer irrespective of LKB1 status. Oncotarget 8:59008-59022
Xiong, Fei; Jiang, Miao; Chen, Meijuan et al. (2017) Study on Inhibitory Effect of MaiMenDong Decoction and WeiJing Decoction Combination with Cisplatin on NCI-A549 Xenograft in Nude Mice and Its Mechanism. J Cancer 8:2449-2455
Gilbert-Ross, Melissa; Konen, Jessica; Koo, Junghui et al. (2017) Targeting adhesion signaling in KRAS, LKB1 mutant lung adenocarcinoma. JCI Insight 2:e90487
Sun, Linlin; Liu, Xiuju; Fu, Haian et al. (2016) 2-Deoxyglucose Suppresses ERK Phosphorylation in LKB1 and Ras Wild-Type Non-Small Cell Lung Cancer Cells. PLoS One 11:e0168793
Jin, Rui; Zhou, Wei (2016) TIF-IA: An oncogenic target of pre-ribosomal RNA synthesis. Biochim Biophys Acta 1866:189-196
Liu, Fakeng; Jin, Rui; Liu, Xiuju et al. (2016) LKB1 promotes cell survival by modulating TIF-IA-mediated pre-ribosomal RNA synthesis under uridine downregulated conditions. Oncotarget 7:2519-31
Feng, Xiuyan; Li, Zenggang; Du, Yuhong et al. (2015) Downregulation of urea transporter UT-A1 activity by 14-3-3 protein. Am J Physiol Renal Physiol 309:F71-8
Owonikoko, Taofeek K; Ramalingam, Suresh S; Miller, Daniel L et al. (2015) A Translational, Pharmacodynamic, and Pharmacokinetic Phase IB Clinical Study of Everolimus in Resectable Non-Small Cell Lung Cancer. Clin Cancer Res 21:1859-68

Showing the most recent 10 out of 105 publications